Meningioma Risk Warning With Progestogen Contraceptives

The European Medicines Agency has issued a warning about a potential link between the use of progestogen-based contraceptives like desogestrel and etonogestrel and a small increased risk of meningioma, a type of brain tumor. This advisory comes after new data suggested that these hormonal contraceptives could slightly elevate the risk. The implications are significant as these contraceptives are widely used, and understanding the potential risks helps in making more informed decisions about contraceptive methods. This alert underscores the importance of ongoing monitoring and research to better understand the long-term effects of hormonal contraceptives.